Please login to the form below

Not currently logged in
Email:
Password:

Astellas files patent suit against Sandoz

Astellas Pharma has filed a lawsuit against generics manufacturer Sandoz relating to a version of Astellas' organ transplantation drug, Prograf, which Sandoz plans to market in Canada

Astellas Pharma has filed a lawsuit against Sandoz, the generic division of Novartis, relating to a version of Astellas' Prograf (tacrolimus hydrate) that Sandoz plans to market in Canada.

The suit, which was filed in the Federal Court of Canada, contains an order prohibiting marketing approval from the Canadian Minister of Health for Sandoz's generic tacrolimus hydrate before the expiration of Astellas' patent for the therapy.

Prograf is currently approved in Canada and elsewhere as an immunosuppressant following organ transplantation.

Sandoz previously launched a generic version of Prograf in the US August 2009.

14th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics